StockData
Privia Health Group, Inc. logo

Privia Health Group, Inc. (PRVA) company profile

PRVANasdaqServices-Health ServicesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 16/3060% above fair value
$24.55+0.88 (+3.72%)

Close on Nov 13, 2026Market cap $3.14BP/E 94.4Yield –

About Privia Health

Services-Health Services, SIC 8000

Privia Health Group, Inc. operates as a physician-enablement company that collaborates with healthcare providers, medical practices, health plans, and health systems. The company organizes clinicians into regional medical groups and accountable care organizations to facilitate both fee-for-service medicine and value-based care programs. Its offerings center on a technology platform that integrates clinical workflows, electronic medical records, patient access tools, and telehealth services. Privia Health also provides management services organizations that deliver administrative support, revenue cycle management, clinical analytics, and group purchasing services. Its primary customers include independent physicians, non-physician clinicians, health systems, commercial payers, government programs, and self-insured employers.

The company maintains operations across 24 states and the District of Columbia, with nine of those states participating exclusively in value-based care arrangements. Its provider network includes 5,380 implemented healthcare professionals practicing across more than 1,300 clinical locations, serving over 5.8 million patients. The provided text does not state the location of the company's headquarters.

Summary of the business section of Privia Health's latest annual report, written by StockData.

Company profile

Company

Legal name
Privia Health Group, Inc.
Headquarters
Arlington, VA
Address
950 N. Glebe Rd., Suite 700 22203
Phone
(571) 366-8850
Employees
1,226, Dec 31, 2025
Industry
Services-Health Services
Incorporated in
Delaware
Fiscal year ends
December 31
Auditor
PricewaterhouseCoopers LLP, Washington, District of Columbia

Stock & identifiers

Ticker
PRVA
Exchange
Nasdaq
IPO date
Apr 30, 2021
Shares outstanding
128M, Jul 31, 2026
Public float
$1.75B, Jun 30, 2025
Filer category
Large accelerated filer
SEC CIK
1759655
CUSIP
74276R102
ISIN
US74276R1023
FIGI
BBG00ZXYXVP9
Share class FIGI
BBG00ZXYXWJ4
EIN
00-0000000

Executives and directors

Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years

NamePositionShares owned
Parth MehrotraChief Executive Officer, Director437,174
David MountcastleEVP & Chief Financial Officer173,548
Edward C. FargisEVP & General Counsel111,979
Opella Finley ErnestDirector6,350
Matthew Shawn MorrisDirector154,858
Lance BerberianDirector16,131
Pamela O. KimmetDirector34,172
Francis S. Soistman JrDirector8,463
Nancy G. CocozzaDirector42,814
Thomas A. McCarthyDirector69,470
David P. KingDirector50,775
Jaewon RyuDirector47,110
David S. WichmannDirector1,341,049
Patricia Anne MarylandDirector42,312

CEO pay and shareholder return

Pay versus performance table from the proxy statement

Fiscal yearCEO total payCEO pay actually paidOther executives (avg)Value of $100 investedPeer group
FY2025$9.24M$12.45M$2.28M$68$95
FY2024$8.20M$2.92M$2.86M$56$78
FY2023
Mr Parth Mehrotra
$17.07M$15.77M$2.09M$66$79
FY2023
Mr Shawn Morris
$679.52K$2.59M$2.09M$66$79
FY2023
Mr.Parth Mehrotra
$17.07M$15.77M$2.09M$66$79
FY2023
Mr.Shawn Morris
$679.52K$2.59M$2.09M$66$79

“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.

Executive compensation, fiscal 2025

Summary compensation table from the latest proxy statement

ExecutiveSalaryStock awardsIncentive payOtherTotalvs. prior year
Parth Mehrotra
Chief Executive Officer
$650.00K$8.59M$1.22M$15.58K$10.47M+28%
David Mountcastle
Executive Vice President and Chief Financial Officer
$390.00K$2.15M$468.00K$15.58K$3.02M+3%
Edward C. Fargis
Executive Vice President and General Counsel
$385.00K$1.61M$346.50K$15.58K$2.36M-27%

Stock and option awards are grant-date fair values, not realized pay. “Other” includes pension value changes and all other compensation. Source proxy statement.

IPO

From the final prospectus (Form 424B4) and the first day of trading

Offering

Type
Initial public offering
Final prospectus filed
Apr 30, 2021
Offer price
$23.00
Securities offered
19,500,000
Gross proceeds
$448.50M
Exchange
Nasdaq
First trading day
Apr 28, 2021
First-day close
$23.000.0%
Lock-up ends (est.)
Oct 25, 2021

“The initial public offering price is $23.00 per share.”

Lock-up end is estimated as 180 days after the first trading day; the prospectus sets the actual terms.

Employees

Headcount reported in annual reports

“As of December 31, 2025, across Privia Health Group, Inc., we had 1,226 employees in 43 states and the District of Columbia.”

Corporate history

Events identified from SEC filings

DateEventDetails
Apr 30, 2021IPOInitial public offering priced (424B4 prospectus)
Apr 26, 2021ListingRegistration of securities on an exchange (Form 8-A)
Mar 11, 2020Name changeName changed from PH Group Parent Corp. to Privia Health Group, Inc.

See a number that looks wrong?